Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
A single centre, placebo controlled, blinded (participant, investigator, outcome assessor)
trial to evaluate the effects of COX-2 inhibition with celecoxib on endothelial function in
healthy male volunteers.